A family of institutions
working together on the Can Ruti Campus

News

21/11/2025 - Research

A new cellular model reveals which mutations drive progression to myelodysplastic syndrome and leukemia in patients with GATA2 deficiency

A research team has created the first humanised cellular model to study GATA2 deficiency, a rare genetic disorder that predisposes individuals to severe blood conditions such as myelodysplastic syndrome and leukaemia. The study shows that, although the initial GATA2 mutation weakens haematopoietic stem cells, it is additional mutations -particularly in the SETBP1 gene- that drive disease progression. 

 

Events

Wednesday 03 December

Title pending

Daria Smalchuk
Innovation in Respiratory Infections and Tuberculosis

IGTP IN NUMBERS

  • 1014

    Contracted and seconded research staff

  • 371

    Active projects

  • 1089

    Publications

  • 613

    Active clinical trials

  • 40

    Patent families

  • 25

    License agreements

  • 9

    Active spin-offs

The IGTP is accredited as Instituto de Investigación Sanitaria (IIS) by the Instituto de Salud Carlos III (Spanish Government)

Instituto de Salud Carlos III


The IGTP is a member of


Governance


With the support of


Accreditation